Michelle A Lowes James A Turton James G Krueger Ross St C Barnetson
10.1186/1471-5945-5-9
BMC Dermatol
2005 Aug 18;5:9.
CC BY
https://pubmed.ncbi.nlm.nih.gov/16109173/
Antibodies, Monoclonal / therapeutic use Immunologic Factors / therapeutic use Lymphocyte Function-Associated Antigen-1 / immunology Psoriasis / drug therapy
Antibodies, Monoclonal / therapeutic use Immunologic Factors / therapeutic use Lymphocyte Function-Associated Antigen-1 / immunology Psoriasis / drug therapy Case Reports Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Adult Antibodies, Monoclonal, Humanized Arthritis, Psoriatic / drug therapy CD11 Antigens Female Humans Male Middle Aged Patient Compliance Psoriasis / immunology Secondary Prevention Antibodies, Monoclonal Antibodies, Monoclonal, Humanized CD11 Antigens Immunologic Factors Lymphocyte Function-Associated Antigen-1 efalizumab
PMC1208875
16109173
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series
2005